The authors of the Anti-drug Antibody Validation Testing and Reporting Harmonization | SpringerLink are requesting feedback to be addressed in a supplement to the manuscript.
The following topics have been identified and will be included in the supplement;
- Correction to the sensitivity calculation
- Addition of a cross-validation section
Please respond with feedback and/or additional topics to be addressed to (Charles) Scott Hottenstein and the corresponding author Heather Mylar by 01-Oct-2022.
------------------------------
(Charles) Scott Hottenstein
Associate Director
GlaxoSmithKline
Collegeville PA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------